Xilis
Latest round
- Series A
Last raised
- Jun 2022
Total raised
- $90M
Investors
- 14
About Xilis
Xilis, Inc.Founded in 2019 and headquartered in Durham, US, Xilis, Inc. focuses on biotechnology and has undergone strategic developments aligning with advancements in precision medicine. The company was founded by Thomas Duke and Xiling Shen.Xilis specializes in advanced diagnostic solutions that leverage proprietary microfluidic technology to analyze patient samples at a cellular level. Their core product offerings include tools for precision oncology, which enable healthcare providers to personalize treatment by understanding tumor biology and response to therapies.Xilis generates revenue primarily through partnerships with healthcare providers and institutions, focusing on B2B transactions. They offer subscription-based access to their diagnostic tools alongside one-time service fees for comprehensive analyses.Xilis, Inc. The company is working on launching new diagnostic products aimed at enhancing precision oncology capabilities. Moreover, Xilis aims to expand its market reach into additional regions in Europe and Asia by 2024, focusing on areas with a high demand for personalized cancer treatment solutions.
Who invested in Xilis
14 investors across 3 rounds
See all investors in Xilis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Xilis
Who invested in Xilis?
Xilis has 14 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Xilis raised?
Xilis has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Xilis last raise money?
Xilis's most recent round on record is a Series A, in Jun 2022.
What does Xilis do?
Xilis is a biotechnology company.
Where is Xilis headquartered?
Xilis is headquartered in Durham, US.
Which VCs invest in companies like Xilis?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Xilis's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Xilis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.